{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T22:33:01Z","timestamp":1790548381213,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:00:00Z","timestamp":1657670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:00:00Z","timestamp":1657670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s11845-022-03043-5","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T15:04:09Z","timestamp":1657724649000},"page":"1435-1445","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Computational insights into missense mutations in HTT gene causing Huntington\u2019s disease and its interactome networks"],"prefix":"10.1007","volume":"192","author":[{"given":"Muneeza Qayyum","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4900-4497","authenticated-orcid":false,"given":"Hira","family":"Mubeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohaira Qayyum","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammara","family":"Masood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Zafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed Iqbal","family":"Wattoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alim un","family":"Nisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,13]]},"reference":[{"key":"3043_CR1","doi-asserted-by":"publisher","unstructured":"Ghosh R, Tabrizi SJ (2018) Chapter 17 - Huntington disease. In: Geschwind DH, Paulson HL, Klein C (eds) Handbook of clinical neurology 147:255\u2013278. https:\/\/doi.org\/10.1016\/B978-0-444-63233-3.00017-8","DOI":"10.1016\/B978-0-444-63233-3.00017-8"},{"issue":"7","key":"3043_CR2","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.drudis.2014.03.005","volume":"19","author":"JM Burgunder","year":"2014","unstructured":"Burgunder JM (2014) Genetics of Huntington\u2019s disease and related disorders. Drug Discovery Today 19(7):985\u2013989. https:\/\/doi.org\/10.1016\/j.drudis.2014.03.005","journal-title":"Drug Discovery Today"},{"issue":"3","key":"3043_CR3","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1172\/JCI17742","volume":"111","author":"AB Young","year":"2003","unstructured":"Young AB (2003) Huntingtin in health and disease. J Clin Investig 111(3):299\u2013302. https:\/\/doi.org\/10.1172\/JCI17742","journal-title":"J Clin Investig"},{"issue":"6","key":"3043_CR4","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a007476","volume":"3","author":"S Finkbeiner","year":"2011","unstructured":"Finkbeiner S (2011) Huntington\u2019s disease. Cold Spring Harb Perspect Biol 3(6):a007476. https:\/\/doi.org\/10.1101\/cshperspect.a007476","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"2","key":"3043_CR5","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1602\/neurorx.1.2.255","volume":"1","author":"RH Myers","year":"2004","unstructured":"Myers RH (2004) Huntington\u2019s disease genetics. NeuroRx the journal of the American Society for Experimental NeuroTherapeutics 1(2):255\u2013262. https:\/\/doi.org\/10.1602\/neurorx.1.2.255","journal-title":"NeuroRx the journal of the American Society for Experimental NeuroTherapeutics"},{"key":"3043_CR6","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1136\/jmg.2007.050930","volume":"44","author":"V Wheeler","year":"2007","unstructured":"Wheeler V, Persichetti F, McNeil S, Mysore J, Mysore S, MacDonald M, Myers R, Gusella J, Wexler N (2007) Factors associated with HD CAG repeat instability in Huntington disease. J Med Genet 44:695\u2013701. https:\/\/doi.org\/10.1136\/jmg.2007.050930","journal-title":"J Med Genet"},{"issue":"4","key":"3043_CR7","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1523\/JNEUROSCI.1865-20.2020","volume":"41","author":"NS Caron","year":"2021","unstructured":"Caron NS, Banos R, Yanick C, Aly AE, Byrne LM, Smith ED, Xie Y, Smith SEP, Potluri N, Findlay Black H, Casal L, Ko S, Cheung D, Kim H, Seong IS, Wild EJ, Song J-J, Hayden MR, Southwell AL (2021) Mutant huntingtin is cleared from the brain via active mechanisms in Huntington disease. J Neurosci 41(4):780. https:\/\/doi.org\/10.1523\/JNEUROSCI.1865-20.2020","journal-title":"J Neurosci"},{"issue":"10","key":"3043_CR8","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41582-020-0389-4","volume":"16","author":"SJ Tabrizi","year":"2020","unstructured":"Tabrizi SJ, Flower MD, Ross CA, Wild EJ (2020) Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities. Nat Rev Neurol 16(10):529\u2013546. https:\/\/doi.org\/10.1038\/s41582-020-0389-4","journal-title":"Nat Rev Neurol"},{"key":"3043_CR9","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1042\/BJ20071619","volume":"412","author":"S Imarisio","year":"2008","unstructured":"Imarisio S, Carmichael J, Korolchuk V, Chen CW, Saiki S, Rose C, Krishna G, Davies J, Ttofi E, Underwood B, Rubinsztein D (2008) Huntington\u2019s disease: from pathology and genetics to potential therapies. Biochem J 412:191\u2013209. https:\/\/doi.org\/10.1042\/BJ20071619","journal-title":"Biochem J"},{"issue":"2","key":"3043_CR10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.59566\/IJBS.2011.7089","volume":"7","author":"Y Sari","year":"2011","unstructured":"Sari Y (2011) Huntington\u2019s disease: from mutant huntingtin protein to neurotrophic factor therapy. International Journal of biomedical science: IJBS 7(2):89\u2013100","journal-title":"International Journal of biomedical science: IJBS"},{"issue":"4","key":"3043_CR11","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.3892\/etm.2016.3566","volume":"12","author":"WJ Huang","year":"2016","unstructured":"Huang WJ, Chen WW, Zhang X (2016) Huntington\u2019s disease: molecular basis of pathology and status of current therapeutic approaches (review). Exp Ther Med 12(4):1951\u20131956. https:\/\/doi.org\/10.3892\/etm.2016.3566","journal-title":"Exp Ther Med"},{"key":"3043_CR12","doi-asserted-by":"crossref","unstructured":"Richard GF (ed) (2020) Trinucleotide repeats: methods and protocols. Humana Press","DOI":"10.1007\/978-1-4939-9784-8"},{"key":"3043_CR13","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1001\/archneur.1993.00540110037003","volume":"50","author":"J Gusella","year":"1993","unstructured":"Gusella J, MacDonald M, Ambrose C, Duyao M (1993) Molecular genetics of Huntington\u2019s disease. Arch Neurol 50:1157\u20131163. https:\/\/doi.org\/10.1001\/archneur.1993.00540110037003","journal-title":"Arch Neurol"},{"key":"3043_CR14","doi-asserted-by":"crossref","unstructured":"Kerkis I et al (2020) Brain-derived neurotrophic factor and stem cell-based technologies in Huntington\u2019s disease therapy","DOI":"10.5772\/intechopen.91226"},{"issue":"2","key":"3043_CR15","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1159\/000443738","volume":"46","author":"MD Rawlins","year":"2016","unstructured":"Rawlins MD, Wexler NS, Wexler AR, Tabrizi SJ, Douglas I, Evans SJW, Smeeth L (2016) The prevalence of Huntington\u2019s disease. Neuroepidemiology 46(2):144\u2013153. https:\/\/doi.org\/10.1159\/000443738","journal-title":"Neuroepidemiology"},{"key":"3043_CR16","doi-asserted-by":"publisher","DOI":"10.2217\/nmt-2016-0008","author":"S Baig","year":"2016","unstructured":"Baig S, Strong M, Quarrell O (2016) The global prevalence of Huntington\u2019s disease: a systematic review and discussion. Neurodegenerative Disease Management. https:\/\/doi.org\/10.2217\/nmt-2016-0008","journal-title":"Neurodegenerative Disease Management"},{"key":"3043_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c3109","volume":"340","author":"MJU Novak","year":"2010","unstructured":"Novak MJU, Tabrizi SJ (2010) Huntington\u2019s disease. BMJ 340:c3109. https:\/\/doi.org\/10.1136\/bmj.c3109","journal-title":"BMJ"},{"issue":"2","key":"3043_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/B978-0-12-801893-4.00003-1","volume":"144","author":"C Kay","year":"2017","unstructured":"Kay C, Hayden M, Leavitt B (2017) Epidemiology of Huntington disease. In 144(2):31\u201346. https:\/\/doi.org\/10.1016\/B978-0-12-801893-4.00003-1","journal-title":"Epidemiology of Huntington disease. In"},{"issue":"1","key":"3043_CR19","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1750-1172-5-40","volume":"5","author":"RAC Roos","year":"2010","unstructured":"Roos RAC (2010) Huntington\u2019s disease: a clinical review. Orphanet J Rare Dis 5(1):40. https:\/\/doi.org\/10.1186\/1750-1172-5-40","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"3043_CR20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1001\/archneur.58.2.273","volume":"58","author":"SC Kirkwood","year":"2001","unstructured":"Kirkwood SC, Su JL, Conneally PM, Foroud T (2001) Progression of symptoms in the early and middle stages of Huntington disease. Arch Neurol 58(2):273\u2013278. https:\/\/doi.org\/10.1001\/archneur.58.2.273","journal-title":"Arch Neurol"},{"key":"3043_CR21","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1196\/annals.1427.034","volume":"1147","author":"HD Rosas","year":"2008","unstructured":"Rosas HD, Salat DH, Lee SY, Zaleta AK, Hevelone N, Hersch SM (2008) Complexity and heterogeneity: what drives the ever-changing brain in Huntington\u2019s disease? Ann N Y Acad Sci 1147:196\u2013205. https:\/\/doi.org\/10.1196\/annals.1427.034","journal-title":"Ann N Y Acad Sci"},{"issue":"9","key":"3043_CR22","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1007\/s00415-012-6428-3","volume":"259","author":"M Politis","year":"2012","unstructured":"Politis M, Piccini P (2012) Positron emission tomography imaging in neurological disorders. J Neurol 259(9):1769\u20131780","journal-title":"J Neurol"},{"key":"3043_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.105009","volume":"143","author":"A Di Pardo","year":"2020","unstructured":"Di Pardo A et al (2020) Treatment with K6PC-5, a selective stimulator of SPHK1, ameliorates intestinal homeostasis in an animal model of Huntington\u2019s disease. Neurobiol Dis 143:105009","journal-title":"Neurobiol Dis"},{"issue":"2","key":"3043_CR24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0166-2236(01)00006-6","volume":"24","author":"CT McMurray","year":"2001","unstructured":"McMurray CT (2001) Huntington\u2019s disease: new hope for therapeutics. Trends Neurosci 24(2):32\u201338. https:\/\/doi.org\/10.1016\/S0166-2236(01)00006-6","journal-title":"Trends Neurosci"},{"issue":"1","key":"3043_CR25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s13311-013-0244-z","volume":"11","author":"S Frank","year":"2014","unstructured":"Frank S (2014) Treatment of Huntington\u2019s disease. Neurotherapeutics the journal of the American Society for Experimental NeuroTherapeutics 11(1):153\u2013160","journal-title":"Neurotherapeutics the journal of the American Society for Experimental NeuroTherapeutics"},{"issue":"5","key":"3043_CR26","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/bib\/bbm031","volume":"8","author":"MG Kann","year":"2007","unstructured":"Kann MG (2007) Protein interactions and disease: computational approaches to uncover the etiology of diseases. Brief Bioinform 8(5):333\u2013346. https:\/\/doi.org\/10.1093\/bib\/bbm031","journal-title":"Brief Bioinform"},{"key":"3043_CR27","first-page":"26","volume":"13","author":"K Srirama","year":"2019","unstructured":"Srirama K, Vineela J, Tejaswi K, Thanmayi M (2019) Huntington\u2019s chorea, a neurological disorder of all ages - bioinformatics approach for its precise diagnosis. Int J Health Sci 13:26\u201330","journal-title":"Int J Health Sci"},{"issue":"7","key":"3043_CR28","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1471-2105-15-S7-S11","volume":"15","author":"J Wen","year":"2014","unstructured":"Wen J, Scoles DR, Facelli JC (2014) Structure prediction of polyglutamine disease proteins: comparison of methods. BMC Bioinformatics 15(7):S11. https:\/\/doi.org\/10.1186\/1471-2105-15-S7-S11","journal-title":"BMC Bioinformatics"},{"issue":"6","key":"3043_CR29","doi-asserted-by":"publisher","first-page":"647","DOI":"10.2174\/1570159X1606180608103840","volume":"16","author":"L Scotti","year":"2018","unstructured":"Scotti L, Scotti MT (2018) Editorial: in silico studies in drug research against neurodegenerative diseases. Curr Neuropharmacol 16(6):647\u2013648. https:\/\/doi.org\/10.2174\/1570159X1606180608103840","journal-title":"Curr Neuropharmacol"},{"issue":"12","key":"3043_CR30","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1080\/07391102.2017.1381646","volume":"36","author":"V Brandi","year":"2018","unstructured":"Brandi V, Di Lella V, Marino M, Ascenzi P, Polticelli F (2018) A comprehensive in silico analysis of huntingtin and its interactome. J Biomol Struct Dyn 36(12):3155\u20133171. https:\/\/doi.org\/10.1080\/07391102.2017.1381646","journal-title":"J Biomol Struct Dyn"},{"issue":"3","key":"3043_CR31","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1136\/jmedgenet-2015-103568","volume":"53","author":"F Lopes","year":"2016","unstructured":"Lopes F, Barbosa M, Ameur A, Soares G, de S\u00e1 J, Dias AI, Oliveira G, Cabral P, Temudo T, Calado E, Cruz IF, Vieira JP, Oliveira R, Esteves S, Sauer S, Jonasson I, Syv\u00e4nen AC, Gyllensten U, Pinto D, Maciel P (2016) Identification of novel genetic causes of Rett syndrome-like phenotypes. J Med Genet 53(3):190\u2013199. https:\/\/doi.org\/10.1136\/jmedgenet-2015-103568","journal-title":"J Med Genet"},{"issue":"12","key":"3043_CR32","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1038\/ejhg.2016.74","volume":"24","author":"LH Rodan","year":"2016","unstructured":"Rodan LH, Cohen J, Fatemi A, Gillis T, Lucente D, Gusella J, Picker JD (2016) A novel neurodevelopmental disorder associated with compound heterozygous variants in the huntingtin gene. European journal of human genetics: EJHG 24(12):1826\u20131827. https:\/\/doi.org\/10.1038\/ejhg.2016.74","journal-title":"European journal of human genetics: EJHG"},{"issue":"3\u20134","key":"3043_CR33","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/hmg\/ddaa283","volume":"30","author":"R Jung","year":"2021","unstructured":"Jung R, Lee Y, Barker D, Correia K, Shin B, Loupe J, Collins RL, Lucente D, Ruliera J, Gillis T, Mysore JS, Rodan L, Picker J, Lee JM, Howland D, Lee R, Kwak S, MacDonald ME, Gusella JF, Seong IS (2021) Mutations causing Lopes-Maciel-Rodan syndrome are huntingtin hypomorphs. Hum Mol Genet 30(3\u20134):135\u2013148. https:\/\/doi.org\/10.1093\/hmg\/ddaa283","journal-title":"Hum Mol Genet"},{"issue":"2","key":"3043_CR34","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.eururo.2012.03.050","volume":"63","author":"J Lindberg","year":"2013","unstructured":"Lindberg J, Klevebring D, Liu W, Neiman M, Xu J, Wiklund P, Wiklund F, Mills IG, Egevad L, Gr\u00f6nberg H (2013) Exome sequencing of prostate cancer supports the hypothesis of independent tumor origins. Eur Urol 63(2):347\u2013353. https:\/\/doi.org\/10.1016\/j.eururo.2012.03.050","journal-title":"Eur Urol"},{"issue":"1","key":"3043_CR35","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/ng.2492","volume":"45","author":"MA Nesbit","year":"2013","unstructured":"Nesbit MA, Hannan FM, Howles SA, Reed AA, Cranston T, Thakker CE, Gregory L, Rimmer AJ, Rust N, Graham U, Morrison PJ, Hunter SJ, Whyte MP, McVean G, Buck D, Thakker RV (2013) Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3. Nat Genet 45(1):93\u201397. https:\/\/doi.org\/10.1038\/ng.2492","journal-title":"Nat Genet"},{"issue":"5","key":"3043_CR36","doi-asserted-by":"publisher","first-page":"402","DOI":"10.4103\/ijn.IJN_261_16","volume":"27","author":"S Krishnamurthy","year":"2017","unstructured":"Krishnamurthy S, Kartha GB, Venkateswaran VS, Prasannakumar M, Mahadevan S, Gowda M, Pelle A, Giachino D (2017) Primary hyperoxaluria type 1 with homozygosity for a double-mutated AGXT allele in a 2-year-old child. Indian journal of nephrology 27(5):402\u2013405. https:\/\/doi.org\/10.4103\/ijn.IJN_261_16","journal-title":"Indian journal of nephrology"},{"issue":"5","key":"3043_CR37","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, Laboratory Quality Assurance Committee ACMG (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in medicine: official journal of the American College of Medical Genetics 17(5):405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genetics in medicine: official journal of the American College of Medical Genetics"},{"issue":"5","key":"3043_CR38","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.ajhg.2008.03.005","volume":"82","author":"JM Milunsky","year":"2008","unstructured":"Milunsky JM, Maher TA, Zhao G, Roberts AE, Stalker HJ, Zori RT, Burch MN, Clemens M, Mulliken JB, Smith R, Lin AE (2008) TFAP2A mutations result in branchio-oculofacial syndrome. Am J Hum Genet 82(5):1171\u20131177. https:\/\/doi.org\/10.1016\/j.ajhg.2008.03.005","journal-title":"Am J Hum Genet"},{"issue":"6","key":"3043_CR39","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.ajhg.2019.04.001","volume":"104","author":"Helbig, I., Lopez-Hernandez, T., Shor, O., Galer, P., Ganesan, S., Pendziwiat, M., Rademacher, A., Ellis, C.A., H\u00fcmpfer, N., Schwarz, N., Seiffert, S., Peeden, J., Shen, J., \u0160t\u011brbov\u00e1, K., Hammer, T.B., M\u00f8ller, R.S., Shinde, D.N., Tang, S., Smith, L., Poduri, A., GRIN Consortium","year":"2019","unstructured":"Helbig I, Lopez-Hernandez T, Shor O, Galer P, Ganesan S, Pendziwiat M, Rademacher A, Ellis CA, H\u00fcmpfer N, Schwarz N, Seiffert S\u00a0(2019) A recurrent missense variant in AP2M1 impairs clathrin-mediated endocytosis and causes developmental and epileptic encephalopathy. Am J Hum Genet 104(6):1060\u20131072. https:\/\/doi.org\/10.1016\/j.ajhg.2019.04.001","journal-title":"Am J Hum Genet"},{"issue":"1","key":"3043_CR40","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2340\/00015555-2510","volume":"97","author":"P Kirchmeier","year":"2017","unstructured":"Kirchmeier P, Zimmer A, Bouadjar B, R\u00f6sler B, Fischer J (2017) Whole-exome-sequencing reveals small deletions in CASP14 in patients with autosomal recessive inherited ichthyosis. Acta Derm Venereol 97(1):102\u2013104. https:\/\/doi.org\/10.2340\/00015555-2510","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"3043_CR41","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.humpath.2008.11.013","volume":"40","author":"YR Kim","year":"2009","unstructured":"Kim YR, Kim KM, Yoo NJ, Lee SH (2009) Mutational analysis of CASP1, 2, 3, 4, 5, 6, 7, 8, 9, 10, and 14 genes in gastrointestinal stromal tumors. Hum Pathol 40(6):868\u2013871. https:\/\/doi.org\/10.1016\/j.humpath.2008.11.013","journal-title":"Hum Pathol"},{"issue":"2","key":"3043_CR42","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s00439-004-1129-3","volume":"115","author":"YH Soung","year":"2004","unstructured":"Soung YH, Lee JW, Kim SY, Park WS, Nam SW, Lee JY, Yoo NJ, Lee SH (2004) Somatic mutations of CASP3 gene in human cancers. Hum Genet 115(2):112\u2013115. https:\/\/doi.org\/10.1007\/s00439-004-1129-3","journal-title":"Hum Genet"},{"issue":"1","key":"3043_CR43","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/bpa.12471","volume":"28","author":"MW Ronellenfitsch","year":"2018","unstructured":"Ronellenfitsch MW, Oh JE, Satomi K, Sumi K, Harter PN, Steinbach JP, Felsberg J, Capper D, Voegele C, Durand G, McKay J, Le Calvez-Kelm F, Schittenhelm J, Klink B, Mittelbronn M, Ohgaki H (2018) CASP9 germline mutation in a family with multiple brain tumors. Brain pathology (Zurich, Switzerland) 28(1):94\u2013102. https:\/\/doi.org\/10.1111\/bpa.12471","journal-title":"Brain pathology (Zurich, Switzerland)"},{"key":"3043_CR44","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/B978-0-12-381328-2.00014-6","volume":"98","author":"A Reiner","year":"2011","unstructured":"Reiner A, Dragatsis I, Dietrich P (2011) Genetics and neuropathology of Huntington\u2019s disease. Int Rev Neurobiol 98:325\u2013372. https:\/\/doi.org\/10.1016\/B978-0-12-381328-2.00014-6","journal-title":"Int Rev Neurobiol"},{"issue":"D1","key":"3043_CR45","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork P, Jensen LJ, Mering CV (2019) STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res 47(D1):D607\u2013D613. https:\/\/doi.org\/10.1093\/nar\/gky1131","journal-title":"Nucleic Acids Res"},{"issue":"21","key":"3043_CR46","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.1016\/j.jmb.2013.07.014","volume":"425","author":"S Stefl","year":"2013","unstructured":"Stefl S, Nishi H, Petukh M, Panchenko AR, Alexov E (2013) Molecular mechanisms of disease-causing missense mutations. J Mol Biol 425(21):3919\u20133936. https:\/\/doi.org\/10.1016\/j.jmb.2013.07.014","journal-title":"J Mol Biol"},{"key":"3043_CR47","doi-asserted-by":"publisher","unstructured":"Wen J, Scoles DR, Facelli JC (2014) Structure prediction of polyglutamine disease proteins: comparison of methods. BMC Bioinform 15 Suppl 7(Suppl 7):S11. https:\/\/doi.org\/10.1186\/1471-2105-15-S7-S11","DOI":"10.1186\/1471-2105-15-S7-S11"},{"issue":"7","key":"3043_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068775","volume":"8","author":"Y Arribat","year":"2013","unstructured":"Arribat Y, Bonneaud N, Talmat-Amar Y, Layalle S, Parmentier ML, Maschat F (2013) A huntingtin peptide inhibits poly Q-huntingtin-associated defects. PLoS ONE 8(7):e68775. https:\/\/doi.org\/10.1371\/journal.pone.0068775","journal-title":"PLoS ONE"},{"key":"3043_CR49","doi-asserted-by":"publisher","unstructured":"Schilling B, Gafni J, Torcassi C, Cong X, Row RH, LaFevre-Bernt MA, Cusack MP, Ratovitski T, Hirschhorn R, Ross CA, Gibson BW, Ellerby LM (2006) Huntingtin phosphorylation sites were mapped by mass spectrometry. Modulation of cleavage and toxicity. J Biolog Chem 281(33):23686\u201323697. https:\/\/doi.org\/10.1074\/jbc.M513507200","DOI":"10.1074\/jbc.M513507200"},{"issue":"8","key":"3043_CR50","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1002\/mds.25500","volume":"28","author":"R Reilmann","year":"2013","unstructured":"Reilmann R (2013) Pharmacological treatment of chorea in Huntington\u2019s disease-good clinical practice versus evidence-based guideline. Movement disorders: official journal of the Movement Disorder Society 28(8):1030\u20131033. https:\/\/doi.org\/10.1002\/mds.25500","journal-title":"Movement disorders: official journal of the Movement Disorder Society"},{"key":"3043_CR51","doi-asserted-by":"publisher","unstructured":"Burgunder JM, Guttman M, Perlman S, Goodman N, van Kammen DP, Goodman L (2011) An international survey-based algorithm for the pharmacologic treatment of chorea in Huntington\u2019s disease. PLoS currents 3:RRN1260. https:\/\/doi.org\/10.1371\/currents.RRN1260","DOI":"10.1371\/currents.RRN1260"},{"key":"3043_CR52","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2147\/DDDT.S138828","volume":"12","author":"M Dean","year":"2018","unstructured":"Dean M, Sung VW (2018) Review of deutetrabenazine: a novel treatment for chorea associated with Huntington\u2019s disease. Drug Des Dev Ther 12:313\u2013319. https:\/\/doi.org\/10.2147\/DDDT.S138828","journal-title":"Drug Des Dev Ther"},{"issue":"4","key":"3043_CR53","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1093\/hmg\/ddt499","volume":"23","author":"KN McFarland","year":"2014","unstructured":"McFarland KN, Huizenga MN, Darnell SB, Sangrey GR, Berezovska O, Cha JH, Outeiro TF, Sadri-Vakili G (2014) MECP2: a novel huntingtin interactor. Hum Mol Genet 23(4):1036\u20131044. https:\/\/doi.org\/10.1093\/hmg\/ddt499","journal-title":"Hum Mol Genet"},{"key":"3043_CR54","doi-asserted-by":"publisher","DOI":"10.1007\/s11845-022-02974-3","author":"H Mubeen","year":"2022","unstructured":"Mubeen H, Farooq M, Rehman AU, Zubair M, Haque A (2022) Gene expression and transcriptional regulation driven by transcription factors involved in congenital heart defects. Ir J Med Sci. https:\/\/doi.org\/10.1007\/s11845-022-02974-3.","journal-title":"Ir J Med Sci"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-022-03043-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-022-03043-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-022-03043-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T14:38:52Z","timestamp":1700836732000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-022-03043-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,13]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["3043"],"URL":"https:\/\/doi.org\/10.1007\/s11845-022-03043-5","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,13]]},"assertion":[{"value":"20 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}